Discover how leading cancer institutions are redefining adherence to clinical pathways. Our latest white paper, “Adherence Redefined: Evolving Approaches to Adherence in Oncology Clinical Pathways,” authored by Joey Pecoraro and Christopher Nüesch from EVERSANA MANAGEMENT CONSULTING, delves into the shifting landscape of oncology treatment adherence.
Key Insights Include:
- The decline in strict adherence measures and the rise of proactive approaches.
- How health systems are balancing pathway adherence with physician autonomy.
- The impact of these changes on pharmaceutical manufacturers and their strategies.
Why Download?
- Stay Informed: Keep up with the latest developments in oncology treatment pathways.
- Gain Insights: Get actionable insights to optimize your engagement strategies with health systems.
- Drive Decisions: Use our findings to inform your approach to pathway adherence and product utilization.
Download the Full White Paper Now
Don’t miss out on this essential resource for healthcare professionals and industry leaders. Fill out the form below to access the full white paper and stay ahead in the evolving landscape of oncology care.
Author
Chris brings over a decade of life sciences consulting experience, from strategy to execution, in market access, commercialization, and brand management for biopharma companies of all sizes. He has a background in life sciences consulting engagements…
Joey is a Consultant at EVERSANA MANAGEMENT CONSULTING with applied life sciences industry experience and scientific research experience. While at EVERSANA, Joey has worked on a number of forward-looking commercial and innovation strategy projects…